Health Care

Health Care


Health Care

View on TED@BCG

Focus on Biopharma

March 2017
Changes to standard operating procedures won’t be enough. To avoid costly drug shortages, biopharma companies need a comprehensive strategy for improving supply chain reliability.
February 2016
Biopharma companies are more focused than ever on the operational performance of clinical development. Benchmarking has identified eight factors associated with improved clinical-development performance.
April 2016
Top-line growth is an imperative for medtech and biopharma. With so much pressure to contain costs, these companies need to find new ways to thrive and grow.


March 2017
Medtech has been a late bloomer in emerging markets, but as demand for health care in these regions increases, local medtech companies are positioned for success.
July 2016
The health care industry is in the midst of sweeping changes. Given high investor expectations and pressure on prices and profit margins, medtech companies must take action.
May 2016
As US hospital systems consolidate, medtech companies that develop a top-quality KAM function will build a powerful advantage in the near and longer terms.

Payers & Providers

December 2016
Growth in the life insurance industry has stalled, pitting insurers against internal asset managers. To achieve higher returns, the parties must close ranks and work together in a structured process.

Decision Making in R&D

January 2016
Despite general challenges to productivity in biopharma R&D, a few companies continue to excel. The key is their superior organizational effectiveness, which enhances cooperative behavior among R&D staff.
December 2013
BCG research published in Nature Reviews Drug Discovery does not show a correlation between company size and the likelihood of R&D success. But if size does not matter, what does?

Value-Based Health Care